On Friday, Mersana Therapeutics Inc (NASDAQ: MRSN) was -4.48% drop from the session before settling in for the closing price of $0.61. A 52-week range for MRSN has been $0.49 – $6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15390.52% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 58.87%. With a float of $86.40 million, this company’s outstanding shares have now reached $122.87 million.
In an organization with 123 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mersana Therapeutics Inc stocks. The insider ownership of Mersana Therapeutics Inc is 30.06%, while institutional ownership is 53.01%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.92% during the next five years compared to 11.93% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
You can see what Mersana Therapeutics Inc (MRSN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Let’s dig in a bit further. During the last 5-days, its volume was 2.9 million. That was inferior than the volume of 8.1 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.44%. Additionally, its Average True Range was 0.11.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 3.88%, which indicates a significant decrease from 9.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.10% in the past 14 days, which was lower than the 144.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2444, while its 200-day Moving Average is $1.8654. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $0.6273. Second resistance stands at $0.6727. The third major resistance level sits at $0.6953. If the price goes on to break the first support level at $0.5593, it is likely to go to the next support level at $0.5367. The third support level lies at $0.4913 if the price breaches the second support level.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are 123,533K outstanding shares of the company, which has a market capitalization of 71.89 million. As of now, sales total 36,860 K while income totals -171,670 K. Its latest quarter income was 12,600 K while its last quarter net income were -11,500 K.
